MCSA Postdoctoral Global Fellowship in Drug Development for Toxin Pharmacology

Hosting Information
Offer Deadline: Thu, 11 Sep 2025 - 23:59
Organisation / Company: Monash University Malaysia
Country: Malaysia
Website
https://www.lancaster.ac.uk/health-and-medicine/
https://www.monash.edu
Email
- s.r.hall@lancaster.ac.uk
- yap.michelle@monash.edu
Description
Background
We seek highly motivated postdoctoral researchers to submit expressions of interest (EOI) for a 3-year Marie Sklodowska-Curie Actions (MSCA) Postdoctoral Global Fellowship in drug development for snake venom toxins-induced necrosis. This prestigious fellowship offers an excellent opportunity for career development and international attachment in pharmacology and toxinology research. The fellowship also opens opportunities for international collaborations between Asia-Pacific and the EU. This fellowship also fosters early career development support.
The candidate will lead innovative research projects in drug development for toxin envenomation, including mechanistic actions, structure-activity relationships, and preclinical assessment.
Upon successful application, you will be hosted in Monash University Malaysia (Dr Michelle Yap – Toxin Pharmacology Lab) for 2 years and 1 year at Lancaster University (Dr Steve R Hall).
Eligibility:
- Must hold a PhD in pharmacology, toxinology, biomedical science, biochemistry or biology-related field at the time of application.
- Meets MSCA requirements for this Global Fellowship: The applicant must be national or long-term resident (5 years+) of an EU Member State or Horizon Europe Associated Country.
- Demonstrates an excellent track record of publications.
- Demonstrates proficiency in research, laboratory, and data analysis skills; bioinformatics knowledge is an added advantage.
- Demonstrates proficiency in writing and communication skills
- Demonstrates ability to work effectively in a team.
To express interest, please submit a CV, and motivation to apply with two recommendation letters from academic supervisors or collaborators. We will contact the shortlisted candidate to prepare for the application.
Closing Date for Applications:
To allow ample preparation time for application and proposal writing, we anticipate the closing date to be 31st March 2025. However, please note that the call will remain open until a suitable candidate is found. Early submissions are encouraged.
Jan 13, 2025 at 10:44 PM